MedTech News
.................... by Andrew Celentano
Heartflow receives FDA clearance for updated plaque analysis platform
The updated algorithm shows a 21% improvement in plaque detection, compared to the original version.
Biolinq wins FDA de novo nod for autonomous, needle-free CGM
Biolinq announced today that it received FDA de novo clearance for its lead product, the Biolinq Shine wearable biosensor.
TSC Life Receives FDA 510(K) Clearance for Fluido® AirGuard System, a Moderate to High Flow Blood and IV Fluid Warming Solution for the Prevention of Hypothermia
DENVER, Sept. 24, 2025 /PRNewswire/ — TSC Life announces FDA clearance of its moderate to high flow blood and fluid warmer, Fluido® AirGuard System, in the U.S.
AI models predict when patients can safely stop long-term antidepressant use
New machine learning models developed by University of South Australia (UniSA) researchers could help clinicians identify when patients can successfully stop long-term antidepressant use.
UK scientists slow Huntington’s disease for first time
UK researchers said Wednesday they had slowed the progression of the fatal neural condition Huntington’s disease for the first time with a groundbreaking new gene therapy.
3D-printed tissue brings new realism to medical training
Researchers at the University of Minnesota Twin Cities have successfully 3D printed lifelike human tissue structures that can be used for medical training for surgeons and doctors
ChatGPT-4o therapeutic chatbot may be as effective as journaling for relationship support
One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot known as “Amanda” for relationship support shows that a single session of chatbot therapy can be as beneficial as evidence-based journaling in assisting with relationship conflict resolution.
Lung-on-a-chip with working immune system protects itself like a living organ
Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with the potential to reshape how we study disease, move beyond animal testing, and administer lifesaving therapies.